Home » ophthalmology cro

Iris Pharma is an independent and private French Ophthalmology CRO. The Ophthalmology CRO company was established in 1989 by Dr Pierre-Paul Elena, who has over 27 years of experience in biotechnology.

For 19 years now, pharmaceutical and biotechnology industries, research institutes and medical device companies of all sizes have chosen to work with our Ophthalmology CRO at any level of the drug development process (ocular drug efficacy studies, ocular services, pharmacokinetic studies).

Extensive experience, trained staff and an excellent knowledge of the pharmaceutical industry coupled with a unique expertise in Ophthalmology CRO anticipate the risks, drive the trials to completion efficiently and insure your success.

Our Ophthalmology CRO provides customized solutions

Iris Pharma is an Ophthalmology CRO helping you by moving a new ocular drug from its conception to marketing approval:

• Providing either a full service or customized Ophthalmology CRO solutions respecting your specific needs.
• Producing the most reliable, accurate and high-quality data.
• Reducing the time needed to perform a study.